R&D

LEUKOCARE provides a next-generation formulation technology platform for the protection of proteins like biopharmaceuticals to allow for the development of better products. The proprietary Stabilizing and Protecting Solutions (SPS®) technologies are offered for development projects of partners in the pharmaceutical and the medical device industry.

The SPS® platform is based on the following three main pillars:

- improvement of thermal stability
- protection during sterilization
- functionalization of medical devices

Our SPS® technologies improve stability and quality of biologics like antibodies, vaccines etc. in dry and liquid formulation and protect proteins in biologically functionalized medical devices like implants, wound dressings, microneedles etc. during sterilization and long term storage. Beyond, we support our partners with related services.

LEUKOCARE is a privately owned biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany.

Stabilizing and Protecting Solutions (SPS®) Technology Platform

What we offer

LEUKOCARE`s SPS® formulation platform improve stability and quality of products employing biologics and other proteins. SPS® stabilize biopharmaceuticals, vaccines and biologic device combination products. Hence, SPS® significantly reduce production costs and logistical efforts.

Our platform is based on three main pillars:
- improvement of thermal stability
- protection during sterilization
- functionalization of medical devices

Based on the SPS®-technologies we are able to stabilize biopharmaceuticals in dry and liquid formulation like vaccines and therapeutic antibodies, to facilitate the functionalization of various surfaces like implants, wound dressings and microneedles etc. and to preserve functionality of proteins during terminal sterilization and long term storage.

What we are looking for

LEUKOCARE is looking for partners to provide its proprietary and patented formulation technologies for stabilization and protection of biopharmaceuticals like vaccines, antibodies etc. as well as combination devices.

Beyond, LEUKOCARE supports its partners with related services and know how in order to evaluate and to implement the SPS® technologies in the partnered products:

- Establishment of accelerated aging models for stability testing
- Development of customized lyophilization protocols
- Development of spray drying and spray freeze drying processes
- Coupling of biological compounds to functionalize surfaces of medical devices
- Conduction of analytics and establishment of biological read outs

Keywords

  • Medical Technology
    • [offer] Cancer diagnostics and therapy
    • [offer] Dialysis, Apheresis
    • [offer] Implants, biomaterials, tissue engineering
  • Pharma
    • [offer] Drug targeting and delivery
    • [offer] Galenics
  • Biotech
    • [offer] Biopharmaceuticals
    • [offer] Drug Delivery/Drug Targeting
  • Components and Services
    • [offer] Contract research

Collaboration sought

  • Research & development
  • Sales partnership
  • Laboratory services
  • Partnership for international development projects

Responsible

Chief Operating Officer

back to list